XML 13 R4.htm IDEA: XBRL DOCUMENT v3.25.3
Condensed Consolidated Statements of Income (Loss) - USD ($)
 3 Months Ended 9 Months Ended
Oct. 31, 2025
Nov. 02, 2024
Oct. 31, 2025
Nov. 02, 2024
Income Statement [Abstract]        
Revenue $ 39,169,000 $ 40,422,000 $ 112,979,000 $ 113,922,000
Cost of Revenue 24,972,000 26,708,000 74,496,000 73,909,000
Gross Profit 14,197,000 13,714,000 38,483,000 40,013,000
Operating Expenses:        
Selling and Marketing 5,593,000 6,752,000 16,877,000 19,140,000
Research and Development 1,898,000 1,843,000 5,017,000 4,859,000
General and Administrative 5,122,000 3,855,000 15,140,000 12,343,000
Goodwill Impairment 297,000   297,000 0
Operating Expenses 12,910,000 12,450,000 37,331,000 36,342,000
Operating Income 1,287,000 1,264,000 1,152,000 3,671,000
Other Income (Expense):        
Interest Expense (827,000) (944,000) (2,609,000) (2,363,000)
Loss on Foreign Currency Transactions (119,000) (67,000) (144,000) (390,000)
Other Income/(Expense), net (91,000) 21,000 (147,000) 53,000
Total Other Income (Expense) (1,037,000) (990,000) (2,900,000) (2,700,000)
Income (Loss) Before Income Taxes 250,000 274,000 (1,748,000) 971,000
Income Tax Provision (Benefit) (128,000) 34,000 (506,000) (139,000)
Net Income (Loss) $ 378,000 $ 240,000 $ (1,242,000) $ 1,110,000
Net Income (Loss) per Common Share-Basic $ 0.05 $ 0.03 $ (0.16) $ 0.15
Net Income (Loss) per Common Share-Diluted $ 0.05 $ 0.03 $ (0.16) $ 0.15
Weighted Average Number of Common Shares Outstanding—Basic 7,632,714 7,524,468 7,601,240 7,500,844
Weighted Average Number of Common Shares Outstanding—Diluted 7,698,497 7,579,883 7,601,240 7,604,771